12:00 AM
May 18, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Cangrelor: Phase III discontinued

The Medicines Co. discontinued the Phase III CHAMPION-PLATFORM trial after an independent review committee said the trial would not demonstrate efficacy necessary for regulatory approval. The placebo-controlled, double-blind, international Phase III trial was evaluating standard care with or without cangrelor in 5,312 patients...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >